The Valley Desk

NCT06644768 · Interventional trial

A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Lung Cancer, Non-small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov